Strategic Blueprint LLC Sells 117 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Strategic Blueprint LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,000 shares of the healthcare conglomerate’s stock after selling 117 shares during the quarter. Strategic Blueprint LLC’s holdings in UnitedHealth Group were worth $2,037,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the business. Macroview Investment Management LLC grew its stake in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. True Wealth Design LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at $31,000. Delos Wealth Advisors LLC grew its position in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the period. Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group during the second quarter valued at $31,000. Finally, Signature Resources Capital Management LLC grew its position in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. HSBC lifted their target price on shares of UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Truist Financial raised their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Robert W. Baird lifted their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. UBS Group raised their price objective on shares of UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Finally, Argus raised their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $614.17.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Down 0.4 %

Shares of NYSE:UNH traded down $2.44 during midday trading on Thursday, hitting $586.10. 77,690 shares of the company’s stock traded hands, compared to its average volume of 4,097,011. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The company has a market cap of $541.22 billion, a PE ratio of 35.97, a P/E/G ratio of 1.63 and a beta of 0.59. The firm’s fifty day moving average price is $541.92 and its two-hundred day moving average price is $510.85. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $592.84.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period in the prior year, the business posted $6.14 EPS. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.43%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.